David A. Siegel Cocrystal Pharma, Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.55 $4,940 - $7,150	-13,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.48 - $0.71 $19,536 - $28,897	-40,700 Reduced 75.79%	13,000 $7,000
Q4 2021 Feb 14, 2022	SELL	$0.65 - $1.02 $2,470 - $3,876	-3,800 Reduced 6.61%	53,700 $35,000
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.25 $58,075 - $71,875	57,500 New	57,500 $60,000
Q4 2020 Feb 16, 2021	SELL	$0.8 - $2.16 $48,400 - $130,680	-60,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.86 - $2.36 $52,030 - $142,780	60,500 New	60,500 $56,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.5M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.